Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Technology:
Neuromodulation
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Headquarters:
Malvern, Pennsylvania, United States
Founded Date:
2003
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
15
Total Funding:
248400000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership